Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves' disease

Acta Biochimica Polonica

Volumn 55, Issue 2, 2008, Pages 371-380

  Horst Sikorska, Wanda ^a   Ignaszak Szczepaniak, Magdalena ^a   Marcinkowska, Michalina ^a   Kaczmarek, Marta ^b   Stajgis, Malgorzata ^c   Slomski, Ryszard ^b,d  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

^c Juraszow Hospital   (Poland)

^d POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Bone mineral density; Graves' disease; VDR polymorphisms

Indexed keywords

EID: 46749105586     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2008_3085     Document Type: Article

References (29)

1. Ban Y, Taniyama M, Ban Y (2000a) Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 85: 4639-4643.
2. Ban Y, Ban Y, Taniyama M, Katagiri T (2000b) Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10: 475-480.
3. Braga V, Sangalli A, Malerba G (2002) Relationship among VDR (BsmI and FokI), COLIA1 and CTR polymorphisms with bone mass, bone turnover markers and sex hormones in men. Calcif Tissue Int 70: 457-462.
4. Chen H, Chen W, Hsu C (2001) Relation of BsmI vitamin D receptor gene polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan. Osteoporos Int 12: 1036-1041.
5. Colin E, Uitterlinden A, Meurs J (2003) Interaction between vitamin D receptor genotype and estrogen receptor alpha genotype influences vertebral fracture risk. J Clin Endocrinol Metab 88: 3777-3784.
6. Collins JE, Heward JM, Nithiyananthan S, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA, Gough SC (2004) Lack of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin Endocrinol 60: 618-624.
7. Deng H, Shen F, Xu F (2002) Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density. J Bone Miner Res 17: 678-686.
8. Diamond T, Nery I, Hales I (1991) A therapeutic dilema: supressive doses of thyroxin significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid cancer. J Clin Endocrinol Metab 72: 1184-1188
9. Diamond T, Vine J, Smart R (1994) Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med 120: 1118-1121.
10. Donner H, Rau H, Walfish P (1997) CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82: 143-146.
11. Ferrari S, Rizolli R, Manen D (1998) Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium and 3′-end region polymorphisms. J Bone Miner Res 13: 925-930.
12. Greenspan S, Greenspan F (1999) The effect of thyroid hormone on skeletal integrity. Ann Intern Med 130: 750-758.
13. Hansen T, Abrahamsen B, Henriksen FL, Hermann AP, Jensen LB, Hørder M, Gram J (1998) Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women. Bone 22: 571-575.
14. Horst-Sikorska W, Wawrzyniak A, Celczyńska-Bajew L (2005) Polymorphism of VDR gene - the most effective molecular marker of osteoporotic bone fractures risk within postmenopausal women from Wielkopolska region of Poland. Endokrynol Pol 2: 233-239 (in Polish).
15. Horst-Sikorska W (2005) Hyperthyroidism In Metabolic disorders of bone. Badurski J, Borgis, eds, pp 210-216, Warszawa (in Polish).
16. Jodar E, Munoz-Torres M, Escobar-Jiminez F (1997) Bone loss in hyperthyroid patients and in former hyperthyroid controlled on medical therapy: influence of aetiology and menopause. Clin Endocrinol 47: 279-285.
17. Langdahl B, Gravholt C, Brixen K (2000) Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fractures. Eur J Clin Invest 30: 608-617.
18. Kalak R, Horst-Sikorska W, Słomski R (2000) Genetic background of osteoporosis. Current state of research. Post Biol Komórki 27: 53-71 (in Polish).
19. Kisakol G, Kaya A, Gonen S (2003) Bone and calcium metabolism in subclinical autoimmune hyper and hypothyroidism. Endocr J 50: 657-661.
20. Kubota M, Yoshida S, Kieda M (2001) Association between two types of vitamin D receptor gene polymorphism and bone status in premenopausal Japanese women. Calcif Tissue Int 68: 16-22.
21. Kuryłowicz A, Ramos-Lopez E, Badenhoop K (2005) Association of the vitamin D receptor (VDR) polymorphisms with Graves' disease in Polish population. Endokrynol Pol 4: 433 (in Polish).
22. Morita A, Iki M, Dohi Y (2004) Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese women. The Japanese population-based osteoporosis (JPOS) study. Int J Epidemiol 33: 979-988.
23. Morrison N, Qi J, Tokita A (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367: 284-287.
24. Morrison N, Qi J, Tokita A (1997) Prediction of bone density from vitamin D receptor alleles (correction). Nature 387: 106.
25. Obermayer-Pietsch B, Fruhauf G, Chararas K (2000) Association of the vitamin D receptor genotype BB with low density in hyperthyroidism. J Bone Miner Res 15: 1950-1955.
26. Ramoz-Lopez E, Kurylowicz A, Bednarczuk T, Paunkovic J, Seidl C, Badenhoop K (2005) Vitamin D receptor polymorphisms are associated with Graves' disease in German and Polish but no in Serbian patients. Thyroid 15: 1125-1130.
27. Rubin L, Hawker G, Peltekova V (1999) Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 14: 633-643.
28. Skowrońska-Jóźwiak E, Adamczewski Z, Marcinkowska M (1999) The influence of suppressive dose of L-thyroxin on bone mineral density in premenopausal and postmenopausal women. Endokrynol Pol 50: 361-366 (in Polish).
29. Walker-Bone K, Walter G, Cooper C (2002) Recent developments in the epidemiology of osteoporosis. Curr Opin Rheumatol 14: 411-415.